These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19709727)
1. Beyond HAART: scientists and activists need to work together. Geffen N Lancet; 2009 Sep; 374(9693):860-1. PubMed ID: 19709727 [No Abstract] [Full Text] [Related]
2. Access to essential medications for HIV/AIDS in South Africa. Andrews S S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797 [No Abstract] [Full Text] [Related]
3. Commentary: most South Africans cannot afford anti-HIV drugs. Achmat Z BMJ; 2002 Jan; 324(7331):217-8. PubMed ID: 11831204 [No Abstract] [Full Text] [Related]
4. UN political declaration on HIV and AIDS: where to begin? Poku NK Lancet; 2016 Aug; 388(10046):743-4. PubMed ID: 27560262 [No Abstract] [Full Text] [Related]
5. Generic drugs battle moves from South Africa to Kenya. Siringi S Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665 [No Abstract] [Full Text] [Related]
6. The (political) economics of antiretroviral treatment in developing countries. Nattrass NJ Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022 [TBL] [Abstract][Full Text] [Related]
7. Progress at last? South Africa relents on HIV drugs. Huff B GMHC Treat Issues; 2003; 17(7-8):16, 15. PubMed ID: 14686317 [No Abstract] [Full Text] [Related]
8. Learning and doing: operational research and access to HIV treatment in Africa. Katzenstein D; Koulla-Shiro S; Laga M; Moatti JP AIDS; 2010 Jan; 24 Suppl 1():S1-4. PubMed ID: 20023435 [No Abstract] [Full Text] [Related]
9. Access to essential drugs, human rights and global justice. Shalev C Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024 [No Abstract] [Full Text] [Related]
10. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability]. Kazatchkine M; Moatti JP Med Sci (Paris); 2008 Dec; 24(12):1007-8. PubMed ID: 19116101 [No Abstract] [Full Text] [Related]
11. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world. Tucker T; Yeats J S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766 [No Abstract] [Full Text] [Related]
12. New trends in HIV disease worldwide. Laurence J AIDS Read; 2003 Dec; 13(12):569-70. PubMed ID: 14959689 [No Abstract] [Full Text] [Related]
13. New resolution on HIV/AIDS announced at the 53rd World Health Assembly. Whyte B Bull World Health Organ; 2000; 78(6):863. PubMed ID: 10916927 [No Abstract] [Full Text] [Related]
14. The right to health and the nevirapine case in South Africa. Annas GJ N Engl J Med; 2003 Feb; 348(8):750-4. PubMed ID: 12594322 [No Abstract] [Full Text] [Related]
15. Affordable antiretroviral drugs for developing countries: dreams of the magic bullet. Razum O; Okoye S Trop Med Int Health; 2001 Jun; 6(6):421-2. PubMed ID: 11422954 [No Abstract] [Full Text] [Related]
16. Medicines for all, not just the rich. Davey S Bull World Health Organ; 2001; 79(4):377-8. PubMed ID: 11357220 [No Abstract] [Full Text] [Related]
17. Improving access to treatment for HIV in sub-Saharan Africa. Bautista-Arredondo S; Wirtz VJ; Bertozzi SM BMJ; 2010 Dec; 341():c6546. PubMed ID: 21123343 [No Abstract] [Full Text] [Related]
18. Antenatal HIV screening and treatment in South Africa: social norms and policy options. Hasnain M Afr J Reprod Health; 2004 Aug; 8(2):77-85. PubMed ID: 15623122 [TBL] [Abstract][Full Text] [Related]
19. Ensuring access to essential medicines: some economic considerations. Maskus KE Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162 [No Abstract] [Full Text] [Related]
20. Access to antiretrovirals in South Africa. Reprod Health Matters; 2001 Nov; 9(18):180. PubMed ID: 11803902 [No Abstract] [Full Text] [Related] [Next] [New Search]